152 related articles for article (PubMed ID: 30467187)
21. Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee.
Dann EJ; Paltiel O
Br J Haematol; 2018 Oct; 183(1):131-133. PubMed ID: 28832981
[No Abstract] [Full Text] [Related]
22. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy of Hodgkin and Non-Hodgkin Lymphoma: A Nonrigid Image-Based Registration Method for Automatic Localization of Prechemotherapy Gross Tumor Volume.
Zaffino P; Ciardo D; Piperno G; Travaini LL; Comi S; Ferrari A; Alterio D; Jereczek-Fossa BA; Orecchia R; Baroni G; Spadea MF
Technol Cancer Res Treat; 2016 Apr; 15(2):355-64. PubMed ID: 25918131
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for the use of radiotherapy in nodal lymphoma.
Hoskin PJ; Díez P; Williams M; Lucraft H; Bayne M;
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):49-58. PubMed ID: 22889569
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma.
Rodríguez-Vigil B; Gómez-León N; Pinilla I; Hernández-Maraver D; Coya J; Martín-Curto L
Curr Probl Diagn Radiol; 2006; 35(4):151-63. PubMed ID: 16814002
[TBL] [Abstract][Full Text] [Related]
26. [18F-FDG uptake of lymphoma lesions of various histological subtypes].
Ma LF; Fan W
Ai Zheng; 2009 Apr; 28(4):425-30. PubMed ID: 19622306
[TBL] [Abstract][Full Text] [Related]
27. Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma.
Kader I; Leavers B; Shashinder S; Wylie B; Chi KK; Sundaresan P
J Laryngol Otol; 2016 Jul; 130 Suppl 4():S45-9. PubMed ID: 27488337
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
Juweid ME
J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
[No Abstract] [Full Text] [Related]
29. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
Mittal BR; Manohar K; Malhotra P; Das R; Kashyap R; Bhattacharya A; Varma N; Varma S
Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
[TBL] [Abstract][Full Text] [Related]
30. FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET.
Laffon E; Marthan R
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1602-1603. PubMed ID: 28523358
[No Abstract] [Full Text] [Related]
31. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Goldschmidt N; Or O; Klein M; Savitsky B; Paltiel O
Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations?
Adams HJA; Kwee TC
Br J Haematol; 2018 Apr; 181(1):122-123. PubMed ID: 28025838
[No Abstract] [Full Text] [Related]
33. Imaging Hodgkin and non-Hodgkin lymphoma in the head and neck.
Aiken AH; Glastonbury C
Radiol Clin North Am; 2008 Mar; 46(2):363-78, ix-x. PubMed ID: 18619385
[TBL] [Abstract][Full Text] [Related]
34. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
35. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
36. PET imaging in lymphoma.
Hutchings M
Expert Rev Hematol; 2009 Jun; 2(3):261-76. PubMed ID: 21082968
[TBL] [Abstract][Full Text] [Related]
37. On the Role of Interim Fluorine-18-Labeled Fluorodeoxyglucose Positron Emission Tomography in Early-Stage Favorable Hodgkin Lymphoma.
Hindié E; Mesguich C; Zanotti-Fregonara P
J Clin Oncol; 2017 Aug; 35(24):2851-2852. PubMed ID: 28682690
[No Abstract] [Full Text] [Related]
38. [Malignant lymphoma and adult T-cell leukemia-lymphoma].
Kato K
Rinsho Ketsueki; 2014 Feb; 55(2):191-200. PubMed ID: 24598187
[No Abstract] [Full Text] [Related]
39. Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? - Response to Adams & Kwee.
Mesguich C; Cazeau AL; Bouabdallah K; Hindié E
Br J Haematol; 2018 Apr; 181(1):124-125. PubMed ID: 28106255
[No Abstract] [Full Text] [Related]
40. Predictive Value of Interim [
Adams HJ; Kwee TC
J Clin Oncol; 2017 Jan; 35(3):370-371. PubMed ID: 28095276
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
